Target intelligence / Profile preview

RNA, U7 small nuclear 200 pseudogene (RNU7-200P)

Target
RNU7-200P
Molecular classification
Pseudogene, Non-coding RNA (snRNA pseudogene)
01

Overview

RNU7-200P (RNA, U7 small nuclear 200 pseudogene) is a human pseudogene corresponding to U7 small nuclear RNA. It is not believed to encode a functional transcript or protein. Functional U7 snRNA is a component of the U7 small nuclear ribonucleoprotein complex, crucial for 3' end processing of replication-dependent histone pre-mRNAs[1][3]. As a pseudogene, RNU7-200P lacks evidence of biological activity and is not considered a therapeutic or drug discovery target. It should be distinguished from the functional U7 snRNA gene, which participates in histone mRNA processing. There is no established disease association, functional role, biomarker value, or pharmacological interaction for RNU7-200P. This entry may be incorrect if intended for a therapeutically actionable target, as it is a non-functional genomic element rather than an active molecular entity[1][2][4].

Other names
RNU7-200PU7 small nuclear RNA 200 pseudogeneU7 snRNA 200 pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None known; as a pseudogene, it is generally considered non-functional(In contrast, the functional U7 snRNA is essential for histone pre-mRNA processing[1][3])
04

Disease associations

Unknown/None specific to RNU7-200PSome pseudogenes have regulatory roles in cancer and other diseases via ceRNA (competitive endogenous RNA) mechanisms, but there is no evidence RNU7-200P is implicated in such[2]

Beyond the preview

Go deeper on RNA, U7 small nuclear 200 pseudogene (RNU7-200P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 200 pseudogene (RNU7-200P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call